Opsoclonus myoclonus: A non-epileptic movement disorder that may present as status epilepticus

Archives of Disease in Childhood

Volumn 94, Issue 11, 2009, Pages 897-899

  Haden, Sarah V ^a   McShane, M A ^a   Holt, C M ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WYCOMBE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BENZODIAZEPINE; CORTICOTROPIN; LORAZEPAM; PARALDEHYDE; PHENYTOIN; PREDNISOLONE;

ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CONVULSION; ENCEPHALITIS; EPILEPTIC STATE; HUMAN; INFANT; INTENSIVE CARE UNIT; INTUBATION; LOADING DRUG DOSE; MALE; MENINGITIS; OPSOCLONUS MYOCLONUS SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; GLUCOCORTICOIDS; HORMONES; HUMANS; INFANT; MALE; MOVEMENT; OPSOCLONUS-MYOCLONUS SYNDROME; PREDNISOLONE; STATUS EPILEPTICUS;

EID: 70350436269     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.160044     Document Type: Article

References (5)

1. Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006;368:222-229 (Pubitemid 44041084)
2. Parisi MT, Hattner RS, Matthay KK, et al. Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus. J Nucl Med 1993;34:1922-1926
3. Kirsten A, Beck S, Fühlhuber V, et al. New autoantibodies in pediatric opsoclonus myoclonus syndrome. Ann N Y Acad Sci 2007;1110:256-260 (Pubitemid 350043014)
4. Klein A, Schmitt B, Boltshauser E. Long-term outcome of ten children with opsoclonus-myoclonus syndrome. Eur J Pediatr 2007;166:359-363 (Pubitemid 46295094)
5. Hammer MS, Larsen MB, Stark CV. Outcome of children with opsoclonus-myoclonus regardless of etiology. Pediatr Neurol 1995;13:21-24